Related Experiment Videos

Pseudomonas aeruginosa in French hospitals between 2001 and 2011: back to susceptibility

C Slekovec1, J Robert, D Trystram

  • 1Service d'Hygiène Hospitalière, Centre Hospitalier Universitaire de Besançon, 3, Boulevard Fleming, 25030, Besançon Cedex, France.

Insights

Antimicrobial resistance in Pseudomonas aeruginosa did not increase in French hospitals between 2001-2011. Multidrug resistance and extensively drug-resistant patterns significantly decreased, contrary to previous surveillance network reports.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health Surveillance

Background:

  • European Antimicrobial Resistance Surveillance Network (EARS-Net) reported increased Pseudomonas aeruginosa resistance in France (2008-2011).
  • Data harmonization by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) influenced EARS-Net findings.
  • Contradictory findings from other national surveillance networks prompted further investigation.

Purpose of the Study:

  • To assess long-term trends (2001-2011) in Pseudomonas aeruginosa antimicrobial drug resistance in French hospitals.
  • To utilize a consistent definition of resistance for accurate trend analysis.
  • To evaluate the validity of EARS-Net findings regarding P. aeruginosa resistance.

Main Methods:

  • Analysis of 34,065 P. aeruginosa isolates from six French hospitals (2001-2011).
  • Exclusion of incomplete data and duplicates.
  • Classification of isolates into resistance patterns (resistant, multidrug-resistant, extensively drug-resistant, wild-type) based on European Centre for Disease Prevention and Control (ECDC) criteria.

Main Results:

  • A significant decrease in resistant, multidrug-resistant, and extensively drug-resistant P. aeruginosa isolates over the study period.
  • A significant increase in wild-type P. aeruginosa isolates.
  • Carbapenem resistance rates increased, while resistance to fluoroquinolones, aminoglycosides, and monobactams significantly decreased. No significant changes in cephalosporin and penicillin resistance.

Conclusions:

  • The study's findings do not support the EARS-Net report of increased P. aeruginosa antimicrobial resistance in France.
  • Antimicrobial drug resistance in P. aeruginosa may have decreased or remained stable in French hospitals over the decade studied.
  • Consistent resistance definitions are crucial for accurate surveillance data interpretation.

Related Concept Videos